Full text is available at the source.
Abstract
Messenger RNA vaccines and gene therapies may exhibit variable therapeutic durability.
- Current research focuses on delivery efficiency, targeting, RNA protection, and early protein expression.
- These factors alone do not fully account for the differences in biological effect persistence.
- An understanding of why some therapies maintain effects while others do not is still lacking.
Simplified